Farallon Capital Management
http://www.faralloncapital.com/farallon/index.htmFarallon Capital Management is an investment firm than manages equity capital for institutions and high net worth individuals. The firm's institutional investors are primarily college endowments and foundations. Farallon primarily invests in businesses and securities that are undergoing change or will appreciate because of an expected event which includes mergers, restructurings, recapitalizations or other major changes. The firm seeks to build strong relationships with the management of companies in which it invests.
View Older Stories View More Recent Stories
-
BioAtla Raises $72.5 Million In Series D Financing
-
Effissimo tells Toshiba that shareholders make good directors
-
MEDNAX Announces Leadership and Board Transitions
-
Form D/A Farallon Capital F5 Inve
-
Form D/A Farallon Capital F5 Inve
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Atento Announces New Board of Directors
-
BGL Business Services Insider - Contact Center Outsourcing Continuing to Gain Market Share, with M&A Acting as a Growth Lever
-
Form 4 Generation Bio Co. For: Jun 16 Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-NT Farallon Capital Europe For: Mar 31
-
Private creditors push back against blanket debt relief for Africa
-
Private Creditors Establish the Africa Private Creditor Working Group (“AfricaPCWG” or the “Group”)
-
Atento Reports Fiscal 2020 First Quarter Results
-
Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress
-
Atento S.A. (ATTO) Reports Institutional Investors to Acquire Bain Capital's Equity in Company
-
Atento Announces Institutional Investors to Acquire Bain Capital's Equity in the Company
-
Form D/A FARALLON CAPITAL OFFSHOR
-
Form D/A Farallon Capital Institu
-
Form D/A Farallon Capital (AM)
-
Form D/A Farallon Capital Partner
-
Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results
-
Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases
-
Environmentalist Tom Steyer ends 2020 Democratic presidential bid
-
Verastem (VSTM) Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
-
Verastem Oncology Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
-
Form SC 13G/A ENANTA PHARMACEUTICALS Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Protagonist Therapeutics Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A DermTech, Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A WESTINGHOUSE AIR BRAKE Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Broadmark Realty Capital Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Ready Capital Corp Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A Savara Inc. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form SC 13G/A ALTABA INC. Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-NT Farallon Capital Europe For: Dec 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
NEWAGE ANNOUNCES NEW MEMBER, ALICIA SYRETT, TO ITS BOARD OF DIRECTORS
-
NEWAGE ANNOUNCES NEW MEMBER, ALICIA SYRETT, TO ITS BOARD OF DIRECTORS
-
Zentalis Pharmaceuticals Raises $85 Million in Oversubscribed Series C Financing to Accelerate Internally-Developed Clinical-Stage Oncology Pipeline
-
Form SC 13G Broadmark Realty Capital Filed by: FARALLON CAPITAL MANAGEMENT LLC
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30

